Vous avez cherché: methylnaltrexonbromid (Danois - Anglais)

methylnaltrexonbromid
methylnaltrexone bromide

relistor methylnaltrexonbromid
relistor methylnaltrexone bromide

aktivt stof: methylnaltrexonbromid.
the active substance is methylnaltrexone bromide.

methylnaltrexonbromid gennemgår moderat vævsfordeling.
methylnaltrexone bromide undergoes moderate tissue distribution.

0,6 ml opløsning (12 mg methylnaltrexonbromid)
0.6 ml of solution (12 mg methylnaltrexone bromide)

1 ml opløsning indeholder 20 mg methylnaltrexonbromid.
one ml of solution contains 20 mg methylnaltrexone bromide.

relistor 12 mg injektion methylnaltrexonbromid s.c.
relistor 12 mg injection methylnaltrexone bromide sc

methylnaltrexonbromid metaboliseres minimalt af cyp-isozymer.
methylnaltrexone bromide is minimally metabolised by cyp isozymes.

methylnaltrexonbromid udskilles i modermælken hos ammende rotter.
methylnaltrexone bromide is excreted via the milk of lactating rats.

hver sprøjte på 0,4 ml indeholder 8 mg methylnaltrexonbromid.
each syringe of 0.4 ml contains 8 mg methylnaltrexone bromide.

dyreforsøg har påvist udskillelse af methylnaltrexonbromid i modermælk.
animal studies have shown excretion of methylnaltrexone bromide in breast milk.

hvert hætteglas på 0, 6 ml indeholder 12 mg methylnaltrexonbromid.
each vial of 0.6 ml contains 12 mg methylnaltrexone bromide.

virkningen af methylnaltrexonbromid hos gravide kvinder er ikke kendt.
the effects of methylnaltrexone bromide in pregnant women are not known.

det vides ikke, om methylnaltrexonbromid udskilles i human modermælk.
lactation it is unknown whether methylnaltrexone bromide is excreted in human breast milk.

relistor er et lægemiddel, der indeholder det aktive stof methylnaltrexonbromid.
relistor is a medicine that contains the active substance methylnaltrexone bromide.

methylnaltrexonbromid er en selektiv antagonist for opioidbinding til my-receptoren.
methylnaltrexone bromide is a selective antagonist of opioid binding at the mu-receptor.

data fra 133 (62 methylnaltrexonbromid, 71 placebo) patienter blev analyseret.
data from 133 (62 methylnaltrexone bromide, 71 placebo) patients were analysed.

virkningsmåde methylnaltrexonbromid er en selektiv antagonist for opioidbinding til my- receptoren.
mode of action methylnaltrexone bromide is a selective antagonist of opioid binding at the mu-receptor.

methylnaltrexonbromid påvirker i mindre grad evnen til at føre motorkøretøj og betjene maskiner.
methylnaltrexone bromide has minor influence on the ability to drive and use machines.

det aktive stof i relistor, methylnaltrexonbromid, er en mu-opioid-receptorantagonist.
the active substance in relistor, methylnaltrexone bromide, is a ‘mu-opioid receptor antagonist’.